The Covishield Vaccine Side Effects Case Reaches Supreme Court, Panel Demanded for Investigation

The Covishield Vaccine Side Effects Case Reaches Supreme Court, Panel Demanded for Investigation

The Covishield Vaccine Side Effects Case Reaches Supreme Court, Panel Demanded for Investigation

Background

AstraZeneca, the British pharmaceutical company, has acknowledged that its COVID-19 vaccine, Vaxzevria (marketed as Covishield in India), can cause blood clot-related side effects in “very rare cases” in Europe. This has raised concerns about the safety of the Covishield vaccine, which has been widely used in India’s vaccination drive.

Covishield Safety Under Scrutiny: Supreme Court Petition Demands Investigation

India’s widely used Covishield vaccine, the local version of AstraZeneca’s COVID-19 vaccine, has come under scrutiny following a petition filed in the Supreme Court on May 1st. The petition, submitted by advocate Vishal Tiwari, raises concerns about the vaccine’s safety and calls for a thorough investigation.

The central argument hinges on AstraZeneca’s recent acknowledgement that its COVID-19 vaccine, AZD1222 (marketed as Covishield in India), can cause blood clots in rare cases. Tiwari further cites a perceived rise in heart attacks and sudden deaths following COVID-19 vaccination, particularly among young people. He suggests a potential link between these incidents and the Covishield vaccine.

To address these concerns, the petition demands the formation of an expert medical panel led by a retired Supreme Court judge. The petitioner proposes including directors and specialists from AIIMS, Delhi, to ensure a comprehensive investigation. Additionally, Tiwari advocates for a “vaccine damage payment system” to compensate individuals who experience severe side effects or death after taking the vaccine.

This development has significant implications for India’s ongoing vaccination drive. A Supreme Court-mandated investigation, if approved, could lead to increased public apprehension regarding Covishield’s safety. This, in turn, might potentially affect vaccination rates, hindering efforts to achieve herd immunity.

On the other hand, if the court upholds the vaccine’s safety based on scientific evidence, it could reassure the public and encourage continued vaccination. It’s crucial to remember that health experts overwhelmingly emphasize the benefits of COVID-19 vaccines, including Covishield, far outweigh the risks of rare side effects.

The Supreme Court’s decision on this petition will likely have a major impact on India’s vaccination strategy. It could either create a hurdle in achieving widespread immunity or serve as a platform to strengthen public confidence in the ongoing vaccination efforts.

Petition in Supreme Court

In light of these concerns, a petition has been filed in the Supreme Court of India seeking the formation of an expert medical panel to investigate the side effects and risk factors of the Covishield vaccine. The petition, filed by lawyer Vishal Tiwari, also calls for the establishment of a ‘vaccine damage payment system’ for those who have suffered severe health setbacks or even death after receiving the vaccine.

Key Points of the Petition

  • The petition highlights AstraZeneca’s admission that its vaccine can cause low platelet count and blood clots in rare cases.
  • It states that over 175 crore doses of Covishield have been administered in India, and there has been a surge in deaths due to heart attacks and sudden unconsciousness after COVID-19.
  • The petition argues that the formation of a medical panel is necessary to thoroughly examine the safety concerns surrounding the Covishield vaccine.
  • It also calls for compensation for those who have been adversely affected by the vaccine.

Current Status

The Supreme Court is yet to hear the petition. The outcome of this case could have significant implications for the use of the Covishield vaccine in India.

Additional Information

  • The petition has been filed in the context of a global debate about the safety of COVID-19 vaccines.
  • While the benefits of these vaccines far outweigh the risks, there have been a few rare cases of serious side effects.
  • It is important to note that the Covishield vaccine has been rigorously tested and has been found to be safe and effective in preventing COVID-19.
  • If you have any concerns about the Covishield vaccine, you should consult with your doctor.

Please note that this is a summary of the news article and does not constitute legal advice. If you have any questions or concerns about the Covishield vaccine, you should consult with a qualified healthcare professional.

Related post

जालंधर-पठानकोट रोड पर भीषण सड़क हादसा, एक महिला की मौत, सात घायल

जालंधर-पठानकोट रोड पर भीषण सड़क हादसा, एक महिला की…

पंजाब के जालंधर-पठानकोट रोड पर डीएवी यूनिवर्सिटी के पास बीती शाम एक दर्दनाक सड़क हादसा हुआ, जिसमें एक महिला की मौके…
Himachal Pradesh Politics: Rajni Patil Meets CM Sukhu Amid Congress Leadership Reshuffle

Himachal Pradesh Politics: Rajni Patil Meets CM Sukhu Amid…

HPCC In-Charge Rajni Patil Meets CM Sukhu Amid Political Reshuffle in Congress In a significant political development, Rajya Sabha MP and…
Weather Update: Rain Likely in Haryana, Temperature Drop Expected After February 21

Weather Update: Rain Likely in Haryana, Temperature Drop Expected…

Haryana to Experience Changing Weather Patterns, Rain Expected in Some Areas The Agricultural Meteorology Department of Chaudhary Charan Singh Haryana Agricultural…

Leave a Reply

Your email address will not be published.